Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ODAC votes against Warner-Lambert's prostate cancer drug

Oct. 20, 1998

Paclitaxel derivatives useful as antitumor agents prepared at BMS

Oct. 20, 1998

DepoTech withdraws MAA for Savedar for solid tumor indication

Oct. 19, 1998

Melatonin prevents doxorubicin-induced cardiotoxicity in rat model

Oct. 19, 1998

New drug delivery technology soon to enter clinical testing

Oct. 19, 1998

Wayne Hughes Institute develops potent new agent for breast cancer

Oct. 16, 1998

Gene for Rx, Dx of liver cancer available for licensing from RCT

Oct. 16, 1998

Scientists at Cell Therapeutics disclose new signal transduction inhibitors

Oct. 16, 1998

New animal model of bone metastasis developed at AntiCancer

Oct. 16, 1998

Novel anticancer agent from ProScript moves into clinical testing

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...